Elicio Therapeutics Ownership | Who Owns Elicio Therapeutics?
Elicio Therapeutics Ownership Summary
Elicio Therapeutics is owned by 9.03% institutional investors, 42.96% insiders, and 48.01% retail investors. Knoll capital management is the largest institutional shareholder, holding 3.93% of ELTX shares.
ELTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Elicio Therapeutics | 9.03% | 42.96% | 48.01% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Knoll capital management | 630.91K | 3.93% | $4.87M |
| Blackrock funding, inc. /de | 43.56K | 0.27% | $336.26K |
| Wiley bros.-aintree capital | 10.00K | 0.06% | $77.20K |
| Moody lynn & lieberson | 10.00K | 0.06% | $77.20K |
| Mayflower financial advisors | 10.00K | 0.06% | $77.20K |
| Cibc private wealth group | 7.00K | 0.04% | $42.56K |
| Raymond james financial | 6.00K | 0.04% | $46.32K |
| Jpmorgan chase | - | - | - |
| Hudson bay capital management lp | - | - | - |
| Jane street group | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Knoll capital management | 630.91K | 3.46% | $4.87M |
| Mayflower financial advisors | 10.00K | 0.01% | $77.20K |
| Moody lynn & lieberson | 10.00K | 0.00% | $77.20K |
| Wiley bros.-aintree capital | 10.00K | 0.00% | $77.20K |
| Cibc private wealth group | 7.00K | 0.00% | $42.56K |
| Raymond james financial | 6.00K | - | $46.32K |
| Jane street group | - | - | - |
| Hudson bay capital management lp | - | - | - |
| Jpmorgan chase | - | - | - |
| Blackrock funding, inc. /de | 43.56K | - | $336.26K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Mayflower financial advisors | 10.00K | 0.01% | 10.00K |
| Wiley bros.-aintree capital | 10.00K | 0.00% | 10.00K |
| Raymond james financial | 6.00K | - | 6.00K |
| Blackrock funding, inc. /de | 43.56K | - | 4.23K |
| Knoll capital management | 630.91K | 3.46% | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hudson bay capital management lp | - | - | -182.73K |
| Jane street group | - | - | -14.99K |
| Jpmorgan chase | - | - | -16.00 |
| Moody lynn & lieberson | 10.00K | 0.00% | - |
| Knoll capital management | 630.91K | 3.46% | - |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wiley bros.-aintree capital | 10.00K | 0.00% | 10.00K | $77.20K |
| Mayflower financial advisors | 10.00K | 0.01% | 10.00K | $77.20K |
| Raymond james financial | 6.00K | - | 6.00K | $46.32K |
Sold Out
| Holder | Change |
|---|---|
| Jpmorgan chase | -16.00 |
| Jane street group | -14.99K |
| Hudson bay capital management lp | -182.73K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 23 | -4.17% | 1,450,816 | -8.85% | 9 | 5.98% | 10 | -41.18% | 5 | 150.00% |
| Mar 31, 2025 | 24 | 41.18% | 1,591,744 | 250.55% | 12 | 88.77% | 17 | 325.00% | 2 | -66.67% |
| Dec 31, 2024 | 17 | -5.56% | 454,072 | -7.61% | 3 | 28.42% | 4 | -60.00% | 6 | 500.00% |
| Sep 30, 2024 | 18 | -5.26% | 491,473 | -24.23% | 3 | 10.95% | 10 | -23.08% | 1 | - |
| Jun 30, 2024 | 19 | 5.56% | 648,667 | 59.59% | 5 | 36.72% | 13 | 62.50% | 1 | -66.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2024 | Chudnovsky Yekaterina | Buy | $20.00M | |
| Jun 28, 2024 | Venkatesan Jay | - | Buy | $250.00K |
| Jun 28, 2024 | Venkatesan Jay | - | Buy | $500.00 |
| Jun 28, 2024 | Chudnovsky Yekaterina | Buy | $8.00M | |
| Jun 28, 2024 | Chudnovsky Yekaterina | Buy | $16.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 1 | - |
| 2024 Q2 | 4 | - |
ELTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools